Anti-D <0.1 IU/mL

Transcription

Anti-D <0.1 IU/mL
In vitro diagnostic medical device
Consult instructions for use
ALBAcheck® - BGS
Harmful
Anti-D <0.1 IU/mL
Manufacturer
For Sensitivity Control of the
Anti-Human Globulin Test
Product Code
INTENDED PURPOSE
ALBAcheck-BGS Anti-D (<0.1 IU/mL) is intended for use as
a sensitivity control of the indirect anti-human globulin test.
REAGENT DESCRIPTION
Described in 1945 by Coombs, Mourant and Race, the
Coombs, or anti-human globulin technique, remains one of
the most important and widely used techniques in blood group
serology. A multiplicity of variables can affect the outcome of
antiglobulin tests and consequently it is good laboratory
practice to employ a procedure which can be used to indicate
the sensitivity and limitations of a test system.
This Anti-D (0<0.1IU/mL) can be used to evaluate the
sensitivity of the indirect anti-human globulin test procedure
performed in the laboratory.
This reagent has been standardised for use by the techniques
described below and therefore its suitability for use in other
techniques cannot be guaranteed.
ADDITIONAL MATERIALS AND REAGENTS REQUIRED
Z262
ALBAcheck®-BGS is a registered trademark for a group of
products manufactured by Alba Bioscience for use as controls
in blood group serology tests.
TEST PROCEDURES
General Information
Human Polyclonal / Indirect Agglutinin
INTRODUCTION
FOR HBsAg, ANTI-HIV 1/2 AND ANTI-HCV. NO KNOWN
TEST METHODS CAN OFFER ASSURANCE THAT
PRODUCTS DERIVED FROM HUMAN BLOOD WILL NOT
TRANSMIT INFECTIOUS DISEASE. APPROPRIATE CARE
SHOULD BE TAKEN IN THE USE AND DISPOSAL OF THIS
PRODUCT.
This reagent is for in vitro professional use only.
This reagent has been prepared from plasma collected from
blood donors. Each individual donation contains IgG anti-D
of less than 10 IU/mL. Some donations may contain IgG
antibodies other than anti-D as minor contaminants.
Conversion to serum was achieved by the addition of
calcium chloride. Excess calcium was removed by the
addition of sodium oxalate. The formulation also contains
0.1% (w/v) sodium azide.
The volume delivered by the reagent dropper bottle is
approximately 40 µL; bearing this in mind, care should be
taken to ensure that appropriate serum:cell ratios are
maintained in all test systems.
This reagent complies with the requirements of Directive
98/79/EC on in vitro Diagnostic Medical Devices and the
recommendations contained in the Guidelines for Blood
Transfusion Services in the United Kingdom.
STORAGE CONDITIONS
The reagent should be stored at 2–8 °C. Do not use if turbid.
Do not dilute. The reagent is stable until the expiry date
stated on the product label.
INTERPRETATION OF LABEL SYMBOLS







PBS pH 7.0  0.2
LISS
R1r reagent red cells
Polyspecific Anti-Human Globulin / Anti-Human IgG
10 x 75 mm or 12 x 75 mm glass test tubes
Pipettes
Centrifuge
RECOMMENDED TECHNIQUES
LISS, 37°C Indirect Antiglobulin

Add 2 volumes of blood grouping reagent to a glass test
tube.

Add 2 volumes of 1.5-2% LISS suspended cells.

Mix the test well and incubate for 15 minutes at 37 °C.

Wash the test 4 times with a large excess of PBS
pH 7.0±0.2 (e.g. 4 mL of PBS per 12 x 75 mm tube).
NOTE: (i)
allow adequate spin time to sediment the red
cells.
(ii) ensure that most of the residual saline is
removed at the end of each wash to leave a ‘dry’ cell
button.

Add two drops of anti-human globulin reagent to each
tube.

Mix thoroughly.

Centrifuge at 1000 g for 10 seconds or at a suitable
alternative g force and time.

Gently shake the tube to dislodge the cell button from
the bottom and observe macroscopically for
agglutination.
PRECAUTIONS FOR USE AND DISPOSAL
NIS, 37°C Indirect Antiglobulin
Batch code
Use by (YYYY-MM-DD)
Storage temperature limitation (2– 8 °C)
This reagent contains 0.1% (w/v) sodium azide (EC No.247852-1) and is classified as harmful. R22 - Harmful if
swallowed.
Sodium azide may react with lead and copper plumbing to
form explosive compounds. If discarded into sink, flush with
a large volume of water to prevent azide build-up.
CAUTION: SOURCE MATERIAL FROM WHICH THIS
PRODUCT IS DERIVED WAS FOUND NON-REACTIVE




Add 2 volumes of blood grouping reagent to a glass test
tube.
Add 1 volume of 2-3% NIS suspended red cells.
Mix the test well and incubate for 45 minutes at 37 °C.
Wash the test 4 times with a large excess of PBS
pH 7.0±0.2 (e.g. 4 mL of PBS per 12 x 75 mm tube).
NOTE: (i)
allow adequate spin time to sediment the red
cells.
(ii) ensure that most of the residual saline is
removed at the end of each wash to leave a ‘dry’ cell
button.

Add two drops of anti-human globulin reagent to each
tube.

Mix thoroughly.

Centrifuge at 1000 g for 10 seconds or at a suitable
alternative g force and time.

Gently shake the tube to dislodge the cell button from
the bottom and observe macroscopically for
agglutination.
ID Micro Typing System
Additional Materials and Reagents Required









ID card "LISS/Coombs”
ID Diluent 2 - modified LISS
ID centrifuge
ID Dispenser
ID Pipettor
ID Pipettor tips
Tubes for cell suspensions
ID working table
ID incubator
Test Procedure






Prepare cell suspension - 12.5 µL packed cells + 1.0 mL
ID Diluent 2.
Add 50 µL cells to the appropriate microtubes.
Add 25 µL of the Anti-D control to each microtube.
Incubate for 15 minutes at 37 oC in the ID incubator.
Centrifuge in the ID centrifuge for 10 minutes.
Read reactions.
INTERPRETATION OF RESULTS
Agglutination
No agglutination
=
=
positive test result
negative test result
QUALITY CONTROL
This is a quality control reagent and its satisfactory
performance when used by the recommended techniques
represents an adequate level of control.
R1r samples will exhibit variable degrees of RhD antigen
expression.
Driblocks and waterbaths promote better heat transfer and
are recommended for 37 °C tests, particularly where the
incubation period is 30 minutes or less.
Tube tests should be read by a ‘tip and roll’ procedure.
Excessive agitation may disrupt weak agglutination and
produce false negative results.
In tube tests it is important to use the recommended g force
during centrifugation as excessive centrifugation can lead to
difficulty in resuspending the cell button, while inadequate
centrifugation may result in agglutinates that are easily
dispersed.
Improper techniques may invalidate the results obtained with
this product.
False positive or false negative results can occur due to
contamination of test materials, improper reaction
temperature, improper storage of materials and omission of
test reagents.
SPECIFIC PERFORMANCE CHARACTERISTICS
Additional Materials and Reagents Required
Anti-IgG,-C3 cards
Ortho BLISS
Ortho BioVue Centrifuge
Ortho BioVue Incubator
Ortho BioVue Pipette
Ortho BioVue Pipette tips
Ortho BioVue workstation
Tubes for cell suspension
Test Procedure






Prepare cell suspension – 10 µL packed cells + 0.8 mL
BLISS.
Add 40 µL of test cells to appropriate microtubes.
Add 40 µL Anti-D control to each microtube.
Incubate for 15 minutes at 37 °C in Ortho BioVue
incubator.
Centrifuge in Ortho BioVue centrifuge for 5 minutes.
Read reactions.
Tel No:
Fax No:
E-Mail:
+44 (0) 131 658 5700
+44 (0) 131 672 3026
customer.serviceEU@quotientbd.com
PERFORMANCE LIMITATIONS
Ortho BioVue® System








Alba Bioscience
Ellen’s Glen Road
Edinburgh
Scotland, UK
EH17 7QT
THIS REAGENT SHOULD ONLY BE USED IN THE
APPLICATIONS DESCRIBED AND IS NOT SUITABLE FOR
RhD GROUPING.
DATE OF ISSUE
20 March 2015
For further information or advice please contact your local
distributor.
 Alba Bioscience 2015
Z262PI/04